Clinical Trials · NCT05819138
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- University of Colorado, Denver
- Enrollment
- 60
- Start date
- Jun 2023
- Locations
- 2 sites, United States
- Primary endpoint
- Change in Ascending Aortic Pulse Wave Velocity (AA PWV)